Tissue Engineering of Ovine Aortic Blood Vessel Substitutes Using Applied Shear Stress and Enzymatically Derived Vascular Smooth Muscle Cells

Compared to native blood vessels, all clinically available blood vessel substitutes perform suboptimally. Numerous approaches to tissue engineer (TE) blood vessels have been pursued using different scaffold materials, cell types, and culture conditions. Several limitations however remain to be overcome prior to the potential application in the arterial system. This study aimed at tissue engineering viable ovine blood vessels suitable for implantation into the systemic circulation of sheep. In recent studies vascular smooth muscle cells (vSMC) were derived by an explant technique. However, in this study we show that homogenous populations of differentiated vSMC were only obtained by enzymatic dispersion as characterized by immunostaining for specific vSMC marker proteins. In contrast the explant method yielded predominantly less differentiated myofibroblast-like cells. Enzymatically derived vSMC were seeded onto P-4-HB scaffolds and incubated either in a pulsatile flow bioreactor or under static conditions. Dynamically cultured TE blood vessel substitutes showed confluent layered tissue formation and were completely water resistant. They displayed significantly increased ECM synthesis, DNA, and protein content as well as vSMC marker expression. Mechanical properties of bioreactor cultured TE blood vessels approached those of native aorta. In conclusion ovine, aortic blood vessel substitutes were successfully created using enzymatically derived vSMC, bioabsorbable scaffolds, and applied shear stress.

[1]  T. Umemura,et al.  Degradation of polyetherurethane by subcutaneous implantation into rats. I. Molecular weight change and surface morphology. , 1994, Journal of biomedical materials research.

[2]  K. Weber,et al.  Heterogeneity of intermediate filament expression in vascular smooth muscle: a gradient in desmin positive cells from the rat aortic arch to the level of the arteria iliaca communis. , 1981, Differentiation; research in biological diversity.

[3]  A. Bader,et al.  [A new concept for substitutes in vascular surgery]. , 1998, Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress.

[4]  Anthony Atala,et al.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.

[5]  R Langer,et al.  Morphologic and mechanical characteristics of engineered bovine arteries. , 2001, Journal of vascular surgery.

[6]  P. Zahradka,et al.  Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall. , 1997 .

[7]  Ralf Sodian,et al.  Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. , 2002, The Annals of thoracic surgery.

[8]  H. Suma Arterial grafts in coronary bypass surgery. , 1999, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[9]  G. Campbell,et al.  Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture , 1977, Cell and Tissue Research.

[10]  R Langer,et al.  Stabilized polyglycolic acid fibre-based tubes for tissue engineering. , 1996, Biomaterials.

[11]  M A Moses,et al.  Tissue engineering of autologous aorta using a new biodegradable polymer. , 1999, The Annals of thoracic surgery.

[12]  J. Campbell,et al.  Culture techniques and their applications to studies of vascular smooth muscle. , 1993, Clinical science.

[13]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[14]  Susan M. Kilroy,et al.  Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures , 2001, Journal of cellular biochemistry.

[15]  Joseph P Vacanti,et al.  Dynamic rotational seeding and cell culture system for vascular tube formation. , 2003, Tissue engineering.

[16]  R Langer,et al.  Creation of viable pulmonary artery autografts through tissue engineering. , 1998, The Journal of thoracic and cardiovascular surgery.

[17]  M A Moses,et al.  Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. , 2000, The Journal of thoracic and cardiovascular surgery.

[18]  R. Sodian,et al.  Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts. , 2001, The Thoracic and cardiovascular surgeon.

[19]  Narutoshi Hibino,et al.  Successful application of tissue engineered vascular autografts: clinical experience. , 2003, Biomaterials.